holomedicine® association

The Holomedicine® Association is a global network of individual experts from medicine, science, technology, and policy. We work to build new methods for delivering mixed reality technologies in medicine and surgery, ensuring they have maximum clinical impact.

    our Mission

    The Holomedicine® Association exists to transform healthcare, and bring the benefits of ground-breaking new technology to all patients. 

    Digital transformation

    Illustrate the breadth of innovation in the field of digital health and raise awareness across clinical communities about the transformative potential of Holomedicine®.


    Establish an appropriate framework for Holomedicine® applications and their integration into the field of digital health.

    Life-changing impact

    Demonstrate the life-changing impact of holomedicine®-based applications to patients.

    High standards

    Set new standards in medical quality, patient safety and data protection, and ensure medical staff are equipped with the information and training they need to deliver holomedicine®-based applications.


    The Holomedicine® Association is pleased to partner with the following organisations:

    What is HOLOmedicine?

    The Holomedicine® Association is not only the first of its kind, but it pioneers a new term – Holomedicine – to describe applications which blend augmented, mixed and virtual reality to allow for the practice and delivery of medicine through sensory camera technology. "Holo" is derived from hologram, whereby medical information such as MRI and CT scans, as well as ultrasound, microscope and endoscope screens, are displayed as holograms. This is viewed through mixed reality glasses while, at the same time, the real-world environment remains completely visible.
    Holomedicine® applications can create a 3-dimensional hologram image of a patient’s anatomy, allowing the surgeon or medical professional to carry out multiple practices including surgical planning and preparation, telesurgery, and training to student physicians.

    Latest news

    Oct 2021

    This month the Holomedicine® Association has been working on its Inaugural Summit taking place as a virtual event on the 27 November 2021.

    The Summit will bring together doctors and experts from around the world, who will showcase their extensive knowledge in healthcare, digital innovation, and technology.

    Sep 2021

    In September, the European Commission together with the Slovenian Presidency organised one of the biggest AI events in Europe: From Ambition to Action’: A High Level Conference on AI. With efforts to make Europe fit for the Digital Age and turn it into the global hub of trustworthy AI, European Commission is putting innovation at the health of policymaking.

    Aug 2021

    The European Commission's Joint Research Centre (JRC) and the Organisation for Economic Co-operation and Development (OECD) have recently published a new report entitled "National strategies on Artificial Intelligence: A European perspective". The report compares AI-related strategies of Member States and identifies areas of collaboration.

    Jul 2021

    WHO issued its first global report on Artificial Intelligence in healthcare and six guiding principles for its design and use, entitled Ethics and Governance of Artificial Intelligence for Health.

    Jun 2021

    Artificial Intelligence (AI) has rapidly matured over the years and can be deployed in just about any activity of the health sector, from clinical decision-making to biomedical research and medicine development. It presents great potential to enhance the efficiency and effectiveness of health care systems, yet its successful application requires a deep understanding of its strengths and…

    May 2021

    For the second half of 2021 Slovenia will hold the Presidency of the Council of the EU. During the 6-month mandate, Digital Minister Boštjan Koritnik aims to reach an agreement with the other EU countries on Artificial Intelligence (AI), with the hope that negotiations can be continued into 2022.

    Today – on World Telecommunication and Information Society Day – the Holomedicine® Association becomes open to new members, signifying a huge step towards the advancement of digital health.

    Apr 2021

    Within the next decade the Artificial Intelligence (AI) healthcare market is predicted to be worth more than $61 billion. The COVID-19 pandemic has seen AI used to detect the virus in chest x-rays. In the context of this enormous growth and social salience, the European Commission (EC) has published its proposal for a ‘Regulation Laying Down Harmonised Rules On Artificial Intelligence (Artificial…

    The Scottish Government has laid out their plans to become a world leader in the development and use of trustworthy, ethical, and inclusive AI in their newly released AI Strategy, complementing the existing UK Government AI Sector Deal and ahead of the forthcoming UK AI Strategy.

    Feb 2021

    Serbia has leveraged AI to lead the world in its immunization efforts. The small Balkan country is ranked 7th globally and 2nd in Europe in the number of people vaccinated against Covid-19.

    Jan 2021

    As COVID-19 continues to focus the worlds minds on global healthcare systems, governments and advisors clamour to attract medical AI research and development.

    Sep 2020

    As the United Kingdom looks set to wind up the Brexit Transition Period in December, the UK has cast back to old allegiances to set new collaborative horizons, with artificial intelligence research and development a central pillar of new economic collaboration.

    Aug 2020

    As part of its long-term response to COVID-19, and its commitment to detecting three-quarters of cancers at an early stage by 2028, the UK Government has announced a further £50 million in funding to support diagnostic centres of excellence in developing AI to diagnose disease.

    Jul 2020

    As innovation in artificial intelligence-based technologies freely progresses in both healthcare and broader society, calls have mounted for regulatory oversight to control, support, and direct AI-based innovations and their application in society. 


    Jun 2020

    AI-powered supercomputing has come to the fore in the European fight against COVID-19. The EU-funded, public and private consortium Exscalate4CoV (E4C) has escalated the fight against COVID-19 through supercomputer-driven drug discovery.

    May 2020

    As COVID-19 continues to disrupt healthcare delivery across the world, telehealth – the provision of healthcare remotely through telecommunication technology – has taken centre stage to support remote and virtual healthcare.

    Apr 2020

    AI is proving to have newfound use in medical imaging of symptoms in COVID-19 patients across the world. The use of AI in diagnostics has proven bountiful over the last few years, and the COVID-19 pandemic has provided further avenues for the application of AI in healthcare.

    Mar 2020

    London’s Middlesex University has announced its new investment into AI technology as a new teaching tool for nursing students.

    Feb 2020

    The European Commission (EC) has published their new Data and AI strategy, which sets out plans to expand Europe’s technological and AI capacities.

    Jan 2020

    In the UK, a new £140million Artificial Intelligence award, which aims to bring life-saving innovation to the NHS, has been launched by the Health secretary Matt Hancock at the ‘Parliament and HealthTech Conference’.

    Contact us

    Contact Form




    If you send us your registration via the registration form, your details from the inquiry form, including the contact details you provided there, will be stored in order to process the request and in case of follow-up questions. We will not share this information without your consent. Your consent is voluntary and you can do so at any time by a simple statement (by e-mail, by mail to RPP GROUP SPRL, Rue Guimard 10, 1040 Brussels, Belgium).


    Cookie settings

    We use cookies on holomedicine-association.org (e.g. tracking and analytical cookies), with which an analysis and measurement of user data is possible. Further information can be found in the